Pharmacogenomics-guided policy in opioid use disorder (OUD) management: An ethnically-diverse case-based approach
Introduction: Opioid use disorder (OUD) is characterized by a problematic pattern of opioid use leading to clinically-significant impairment or distress. Opioid agonist treatment is an integral component of OUD management, and buprenorphine is often utilized in OUD management due to strong clinical...
Main Authors: | Earl B. Ettienne, Edwin Chapman, Mary Maneno, Adaku Ofoegbu, Bradford Wilson, Beverlyn Settles-Reaves, Melissa Clarke, Georgia Dunston, Kevin Rosenblatt |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | Addictive Behaviors Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352853217300111 |
Similar Items
-
Pharmacogenomic considerations in opioid analgesia
by: Vuilleumier PH, et al.
Published: (2012-08-01) -
Pharmacogenomics and Opioid Analgesics: Clinical Implications
by: Eugenia Yiannakopoulou
Published: (2015-01-01) -
 Pharmacogenomic considerations in opioid analgesia. [Corrigendum]
by: Vuilleumier PH, et al.
Published: (2013-01-01) -
Predictors of hepatitis C testing intention among African American Baby Boomers
by: Mohamed Rashrash, et al.
Published: (2019-04-01) -
Linking Pharmacogenomic Information on Drug Safety and Efficacy with Ethnic Minority Populations
by: Dan Li, et al.
Published: (2020-10-01)